Andreas Boettcher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andreas Boettcher

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Nature Communications|September 7, 2023

Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1βUlrich Hommel, Konstanze Hurth, Jean-Michel Rondeau, et al.

Journal of Medicinal Chemistry|November 22, 2024

Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 InflammasomeAngela Mackay, Juraj Velcicky, Nina Gommermann, et al.

Science Signaling|January 17, 2023

Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysisEmilia Neuwirt, Giovanni Magnani, Tamara Ćiković, et al.

Journal of Medicinal Chemistry|May 10, 2024

Ligandability Assessment of IL-1β by Integrated Hit Identification ApproachesAnna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, et al.

Immunity|February 4, 2025

NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progressionRóisín M McManus, Max P Komes, Angelika Griep, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Nature Communications|September 7, 2023

Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1βUlrich Hommel, Konstanze Hurth, Jean-Michel Rondeau, et al.

Journal of Medicinal Chemistry|November 22, 2024

Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 InflammasomeAngela Mackay, Juraj Velcicky, Nina Gommermann, et al.

Science Signaling|January 17, 2023

Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysisEmilia Neuwirt, Giovanni Magnani, Tamara Ćiković, et al.

Journal of Medicinal Chemistry|May 10, 2024

Ligandability Assessment of IL-1β by Integrated Hit Identification ApproachesAnna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, et al.

Immunity|February 4, 2025

NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progressionRóisín M McManus, Max P Komes, Angelika Griep, et al.

Pageof 2